# EDGAR Filing Document

**Accession Number:** 0000062234
**File Stem:** 0000897069-25-001127
**Filing Date:** 2025-6
**Character Count:** 12322
**Document Hash:** 7df8ac610df808e4acc7a1a7b69677f4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000897069-25-001127.hdr.sgml**: 20250624

**ACCESSION NUMBER**: 0000897069-25-001127

**CONFORMED SUBMISSION TYPE**: 3/A

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230531

**FILED AS OF DATE**: 20250624

**DATE AS OF CHANGE**: 20250624

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Evans Michael Reade
- **CENTRAL INDEX KEY:** 0001988495

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12604
- **FILM NUMBER:** 251069733

**MAIL ADDRESS:**
- **STREET 1:** 100 EAST WISCONSIN AVENUE
- **STREET 2:** SUITE 1900
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202-4125
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MARCUS CORP
- **CENTRAL INDEX KEY:** 0000062234
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MOTION PICTURE THEATERS [7830]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 391139844
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 111 EAST KILBOURN AVENUE
- **STREET 2:** SUITE 1200
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202-6633
- **BUSINESS PHONE:** 4149051000

**MAIL ADDRESS:**
- **STREET 1:** 111 EAST KILBOURN AVENUE
- **STREET 2:** SUITE 1200
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202-6633

## Ex-24

### Power of Attorney

The undersigned as a Section 16 reporting person of The Marcus Corporation (the "Company"), hereby constitutes and appoints Steven R. Barth and Garrett F. Bishop, and any of their substitutes, signing singly, the undersigned's true and lawful attorney-in-fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) execute, deliver and file for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of the Company, Forms 3, 4, and 5 in accordance with Section 16(a) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. The undersigned further acknowledges and agrees that the attorney-in-fact and the Company are relying on written and oral information provided by the undersigned to complete such forms and the undersigned is responsible for reviewing the completed forms prior to their filing. The attorney-in-fact and the Company are not responsible for any errors or omissions in such filings. The attorney-in-fact and the Company are not responsible for determining whether or not the transactions reported could be matched with any other transactions for the purpose of determining liability for short-swing profits under Section 16(b).

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

*[Signature page follows.}*

** 

<br> ------

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this July 21, 2023.

<u>/s/ Michael Reade Evans</u>

<br> Name: Michael Reade Evans<br>

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Evans Michael Reade<br><sub>(Last) (First) (Middle)</sub><br>100 EAST WISCONSIN AVENUE<br>SUITE 1900<br><sub>(Street)</sub><br>MILWAUKEE, WI 53202-4125<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-05-31 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Pres., Marcus Hotels & Resorts_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>MARCUS CORP [ MCS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 1334<sup>(1)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 2450<sup>(2)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 3450<sup>(3)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 4300<sup>(4)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 936.8786<sup>(5)</sup> | I | By 401K Plan |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | $31.11 |  |  |  |  |  |  | <sup>(6)</sup> | 2030-01-08 | Common Stock | 32506 |  |  | D |  |
| Stock Option (Right to Buy) | $28.88 |  |  |  |  |  |  | <sup>(6)</sup> | 2030-02-25 | Common Stock | 7117 |  |  | D |  |
| Stock Option (Right to Buy) | $12.71 |  |  |  |  |  |  | <sup>(6)</sup> | 2030-05-08 | Common Stock | 20000 |  |  | D |  |
| Stock Option (Right to Buy) | $21.84 |  |  |  |  |  |  | <sup>(6)</sup> | 2031-03-09 | Common Stock | 23000 |  |  | D |  |
| Stock Option (Right to Buy) | $17.04 |  |  |  |  |  |  | <sup>(6)</sup> | 2032-03-08 | Common Stock | 30000 |  |  | D |  |
| Stock Option (Right to Buy) | $15.99 |  |  |  |  |  |  | <sup>(6)</sup> | 2033-03-07 | Common Stock | 35000 |  |  | D |  |

---

### Footnotes:

(1) Restricted stock granted February 19, 2020 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.

(2) Restricted stock granted February 25, 2021 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.

(3) Restricted stock granted February 23, 2022 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.

(4) Restricted stock granted March 1, 2023 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.

(5) Balance reflects the most current data available with regard to the reporting person's holdings in the 401(k) Plan. This amount was not previously reported on the Form 3 filed on August 14, 2023.

(6) The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.

**Signature:** /s/ Steven R. Barth, Attorney-in-Fact for
Michael Reade Evans  
**Date:** 2025-06-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**